Validity and Reliability of the Hypertonia Assessment Tool (HAT) in Stroke Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFatih Sultan Mehmet Training and Research Hospital
About this trial
In this study, the validity and reliability of the Hypertonia Assessment Tool (HAT), which has previously been validated in the pediatric cerebral palsy (CP) population, will be evaluated in adult individuals who have experienced a stroke. The HAT is a specific clinical instrument designed to differentiate subtypes of hypertonia, including spasticity, dystonia, and rigidity.
Accurate classification of hypertonia subtypes following stroke is crucial for guiding rehabilitation strategies. However, the HAT has not yet been validated in the adult post-stroke population. This study will be conducted at the Physical Medicine and Rehabilitation Clinic of SBU Fatih Sultan Mehmet Training and Research Hospital. The study aims to evaluate the validity and reliability of the HAT for use in adults with stroke.
Eligibility criteria
Qualifiers
Age 18 years and older
Clinically and radiologically confirmed diagnosis of stroke (ischemic or -hemorrhagic)
Brunnstrom stage between 2 and 6
Presence of post-stroke hypertonia (spasticity, dystonia, or rigidity)
Disqualifiers
Age under 18 years
Presence of severe accompanying neurodegenerative diseases (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis)
Presence of primary musculoskeletal disorders affecting motor performance (e.g., rheumatologic diseases, fractures)
Brunnstrom stage of 1
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov